Pancreatic Cancer Research

ResearcherFirst Hospital of China Medical UniversityNo recent work listed

Yunwei Li

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 8 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2016: 1 paper · 2017: 1 paper

Papers 2

  1. Cooperation of Musashi-2, Numb, MDM2, and P53 in drug resistance and malignant biology of pancreatic cancer. Co-author DOI 10.1096/fj.201601240r↗
  2. Co-expression of FOXL1 and PP2A inhibits proliferation inducing apoptosis in pancreatic cancer cells via promoting TRAIL and reducing phosphorylated MYC. Co-author DOI 10.3892/or.2016.4592↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Weiwei Sheng · 2 shared papers, 2016–2017 · strength 0.14
  2. Ming Dong · 2 shared papers, 2016–2017 · strength 0.14
  3. Yuji Li · 2 shared papers, 2016–2017 · strength 0.14
  4. Kewei Wang · 1 shared paper, 2017 · strength 0.07
  5. Jianping Zhou · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.